ProShare Advisors LLC cut its stake in The Allstate Corporation (NYSE:ALL – Free Report) by 3.2% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 60,004 shares of the insurance provider’s stock after selling 2,014 shares during the period. ProShare Advisors LLC’s holdings in Allstate were worth $13,312,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors also recently modified their holdings of the stock. BlackRock Inc. bought a new stake in shares of Allstate during the second quarter valued at approximately $5,439,448,000. Bank of America Corp DE raised its position in Allstate by 8.1% in the 1st quarter. Bank of America Corp DE now owns 7,913,320 shares of the insurance provider’s stock worth $1,640,748,000 after purchasing an additional 596,321 shares during the last quarter. GQG Partners LLC bought a new position in Allstate in the 2nd quarter worth approximately $1,245,710,000. Deutsche Bank AG bought a new position in Allstate in the 2nd quarter worth approximately $1,008,648,000. Finally, Dimensional Fund Advisors LP lifted its holdings in Allstate by 5.8% during the 1st quarter. Dimensional Fund Advisors LP now owns 2,804,615 shares of the insurance provider’s stock worth $581,515,000 after buying an additional 154,259 shares in the last quarter. 76.47% of the stock is owned by institutional investors.
Insider Buying and Selling at Allstate
In other Allstate news, COO Mario Rizzo sold 56,225 shares of the company’s stock in a transaction on Tuesday, August 11th. The shares were sold at an average price of $264.48, for a total transaction of $14,870,388.00. Following the completion of the sale, the chief operating officer owned 82,227 shares in the company, valued at approximately $21,747,396.96. The trade was a 40.61% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider John Dugenske sold 32,996 shares of the stock in a transaction on Friday, August 7th. The shares were sold at an average price of $269.33, for a total value of $8,886,812.68. Following the completion of the transaction, the insider directly owned 13,054 shares in the company, valued at approximately $3,515,833.82. This trade represents a 71.65% decrease in their position. The SEC filing for this sale provides additional information. Insiders own 1.55% of the company’s stock.
Allstate Stock Down 0.9%
Shares of NYSE:ALL opened at $261.55 on Wednesday. The company has a debt-to-equity ratio of 0.24, a current ratio of 0.36 and a quick ratio of 0.36. The stock has a market cap of $66.14 billion, a price-to-earnings ratio of 5.22, a P/E/G ratio of 0.58 and a beta of 0.13. The company has a 50 day moving average of $245.62 and a 200-day moving average of $228.78. The Allstate Corporation has a one year low of $191.13 and a one year high of $277.22.
Allstate (NYSE:ALL – Get Free Report) last announced its quarterly earnings data on Wednesday, August 5th. The insurance provider reported $8.99 earnings per share for the quarter, beating the consensus estimate of $6.06 by $2.93. Allstate had a net margin of 18.97% and a return on equity of 41.64%. The business had revenue of $18.60 billion for the quarter, compared to analyst estimates of $15.46 billion. During the same period in the prior year, the business posted $5.94 earnings per share. Allstate’s revenue was up 11.8% compared to the same quarter last year. On average, sell-side analysts forecast that The Allstate Corporation will post 36.21 earnings per share for the current year.
Analyst Ratings Changes
A number of brokerages have commented on ALL. Weiss Ratings upgraded Allstate from a “buy (a)” rating to a “buy (a+)” rating in a research report on Thursday, October 29th. Piper Sandler reissued an “overweight” rating on shares of Allstate in a research note on Monday, September 28th. Raymond James Financial restated a “strong-buy” rating and set a $315.00 target price (up from $300.00) on shares of Allstate in a research report on Tuesday, August 11th. Barclays cut their price target on Allstate from $226.00 to $221.00 and set an “underweight” rating on the stock in a research note on Wednesday, October 7th. Finally, Roth Capital set a $300.00 price target on Allstate in a report on Thursday, August 6th. Two equities research analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating, nine have issued a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $270.19.
View Our Latest Stock Report on ALL
Allstate Profile
Allstate Corp. (NYSE: ALL) is an insurance company that provides protection products and related services primarily in the United States. Its offerings include automobile, homeowners, renters, condominium, motorcycle and other personal property and casualty insurance, distributed through agents, brokers, direct channels and digital platforms.
The company also provides roadside assistance, identity-protection services and protection plans for consumer products. Through its acquisition of National General, Allstate expanded its presence in independent-agent distribution and specialty personal insurance.
Featured Articles
- Five stocks we like better than Allstate
- Marriott’s Earnings Beat Shows Why It’s More Than a Bet on Travel Demand
- Franklin Templeton’s New ETFs Turn Stock Dividends Into Bitcoin—What’s the Catch?
- Apple’s Earnings Beat Comes With a Catch for Investors Heading Into the Holidays
- Palantir’s $2.3 Billion Quarter Puts Its Premium Valuation to the Test
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Corporation (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.
